| Literature DB >> 26295583 |
Prasanna Vidyasekar1, Pavithra Shyamsunder1, Rajpranap Arun1, Rajalakshmi Santhakumar1, Nand Kishore Kapadia2, Ravi Kumar3, Rama Shanker Verma1.
Abstract
Zero gravity causes several changes in metabolic and functional aspects of the human body and experiments in space flight have demonstrated alterations in cancer growth and progression. This study reports the genome wide expression profiling of a colorectal cancer cell line-DLD-1, and a lymphoblast leukemic cell line-MOLT-4, under simulated microgravity in an effort to understand central processes and cellular functions that are dysregulated among both cell lines. Altered cell morphology, reduced cell viability and an aberrant cell cycle profile in comparison to their static controls were observed in both cell lines under microgravity. The process of cell cycle in DLD-1 cells was markedly affected with reduced viability, reduced colony forming ability, an apoptotic population and dysregulation of cell cycle genes, oncogenes, and cancer progression and prognostic markers. DNA microarray analysis revealed 1801 (upregulated) and 2542 (downregulated) genes (>2 fold) in DLD-1 cultures under microgravity while MOLT-4 cultures differentially expressed 349 (upregulated) and 444 (downregulated) genes (>2 fold) under microgravity. The loss in cell proliferative capacity was corroborated with the downregulation of the cell cycle process as demonstrated by functional clustering of DNA microarray data using gene ontology terms. The genome wide expression profile also showed significant dysregulation of post transcriptional gene silencing machinery and multiple microRNA host genes that are potential tumor suppressors and proto-oncogenes including MIR22HG, MIR17HG and MIR21HG. The MIR22HG, a tumor-suppressor gene was one of the highest upregulated genes in the microarray data showing a 4.4 log fold upregulation under microgravity. Real time PCR validated the dysregulation in the host gene by demonstrating a 4.18 log fold upregulation of the miR-22 microRNA. Microarray data also showed dysregulation of direct targets of miR-22, SP1, CDK6 and CCNA2.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26295583 PMCID: PMC4546578 DOI: 10.1371/journal.pone.0135958
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effect of microgravity on cell morphology and cell viability of DLD-1 cell cultures.
A DLD-1 cell cultures; Static culture (control) B DLD-1 Microgravity culture at 16 RPM C DLD-1 Microgravity culture at 27RPM Differential staining to detect apoptotic population D DLD-1Static monolayer cultures E Microgravity cultures of DLD1 at 16 RPM F Microgravity cultures of DLD1 at 27 RPM G Cell adhesion and proliferation assay Top panel—static cultures, bottom panel—microgravity cultures shifted to static TCP H Morphological changes in DLD-1; Crystal violet staining of DLD-1 cells in static monolayer culture I Crystal violet staining of DLD-1 cells after transfer of cell aggregates from microgravity to TCP J Colony forming ability assay; Static cultures K Colony forming ability assay; DLD-1 cells after transfer of cell aggregates from microgravity to TCP
Fig 2Effect of microgravity on cell viability and cell cycle of DLD-1 and MOLT-4 cell lines.
A Cell viability assay for DLD-1 cells; Viability measured for microgravity cultures (16 RPM and 27 RPM) and static cultures using MTT B Cell cycle analysis for DLD-1 cells; Static C Cell cycle analysis; Microgravity D Cell cycle analysis; Static suspensions on agar underlays E The average sub G0 population in replicates of cell cycle analysis for microgravity, static and static suspension cultures of DLD-1 cells F MOLT-4 cell culture Static and Microgravity cultures of MOLT-4 G Cell viability assay Viability measured for microgravity cultures (16 RPM and 27 RPM) and static cultures using MTT H Cell cycle analysis; Static I Cell cycle analysis; Microgravity cultures of MOLT-4.
Fig 3Quantitative PCR analysis for changes in mRNA expression of significant, candidate genes involved in cell proliferation and cancer.
A CDK1—Cell cycle kinase gene, CD117—proto-oncogene, JUNB—transcription factor and immediate early gene, MYC—proto-oncogene expression in DLD-1 and MOLT-4 B Real time PCR analysis in HL-60 CCNE1 and CDK2, CCNB1 and CDK1, Oncogenes: CD117 and MYC, Cancer prognostic markers CD105, CD90 and CD71.
Commonly deregulated genes in DLD-1 and MOLT-4 cells under microgravity.
|
| |||
|
|
|
|
|
|
| arrestin domain containing 3 | 3.6286426 | 2.5424619 |
|
| activating transcription factor 3 | 2.6872826 | 1.0043197 |
|
| cell cycle progression 1 | 1.5802538 | 1.8111625 |
|
| CDKN2A interacting protein | 1.6052608 | 1.0670295 |
|
| cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 1.3287859 | 1.0733795 |
|
| CREB binding protein | 1.6003945 | 1.1786065 |
|
| CREB3 regulatory factor | 1.7348738 | 1.2481394 |
|
| chemokine (C-X-C motif) ligand 3 | 1.6632779 | 1.1129959 |
|
| DNA-damage-inducible transcript 3 | 2.0701203 | 1.280817 |
|
| early growth response 2 | 1.3966465 | 3.9244506 |
|
| v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 1.3279192 | 1.0439773 |
|
| ets variant 5 | 1.2021747 | 2.488372 |
|
| fibroblast growth factor 7 | 2.2669797 | 1.1106136 |
|
| golgin, RAB6-interacting | 1.1204505 | 1.0041857 |
|
| histone deacetylase 9 | 1.0828898 | 1.4470437 |
|
| histidine triad nucleotide binding protein 3 | 1.7376733 | 1.7083709 |
|
| human immunodeficiency virus type I enhancer binding protein 2 | 1.2518463 | 1.2009206 |
|
| insulin receptor substrate 2 | 2.5675535 | 1.0355048 |
|
| jun proto-oncogene | 2.8459454 | 3.4484391 |
|
| microRNA 1304 | 1.694859 | 1.0175457 |
|
| nuclear receptor coactivator 7 | 1.3721471 | 1.0397696 |
|
| Nedd4 family interacting protein 2 | 1.0812235 | 1.1697233 |
|
| progesterone immunomodulatory binding factor 1 | 1.6272297 | 1.2976668 |
|
| pleckstrin homology domain containing, family F (with FYVE domain) | 2.5150435 | 1.105514 |
|
| phosphatase and tensin homolog | 1.2177935 | 1.0146773 |
|
| RAB30, member RAS oncogene family | 1.8227141 | 1.6890364 |
|
| SKI-like oncogene | 1.7823422 | 1.4903564 |
|
| SMAD family member 7 | 1.0359683 | 1.338062 |
|
| tumor necrosis factor, alpha-induced protein 3 | 1.2988296 | 1.3440051 |
|
| X-linked inhibitor of apoptosis | 1.3545609 | 1.2860351 |
|
| zinc finger, AN1-type domain 2A | 1.9506464 | 1.2355728 |
|
| zinc finger protein, Y-linked | 2.238248 | 1.2044845 |
|
| zinc finger, MYM-type 5 | 1.7800057 | 1.4686751 |
|
| |||
|
|
|
|
|
|
| acid-sensing (proton-gated) ion channel 1 | -1.1945584 | -1.4278164 |
|
| CD24 molecule | -2.1321063 | -1.3863628 |
|
| cell division cycle associated 7-like | -1.6832285 | -1.0647273 |
|
| cyclin-dependent kinase inhibitor 1C (p57, Kip2) | -1.2500896 | -1.0963018 |
|
| dihydrofolate reductase | -1.8050942 | -1.0276904 |
|
| dynein heavy chain domain 1 | -1.464865 | -1.0485542 |
|
| deoxyuridine triphosphatase | -1.0620422 | -1.175415 |
|
| eukaryotic translation elongation factor 1 alpha 1 | -1.0099685 | -1.0678835 |
|
| eukaryotic translation initiation factor 4A1 | -1.0106502 | -1.0274181 |
|
| endosulfine alpha | -1.0821726 | -1.1114485 |
|
| Fanconi anemia, complementation group L | -1.2304835 | -1.0152798 |
|
| fatty acyl CoA reductase 1 | -1.0487332 | -1.0339952 |
|
| fibroblast growth factor receptor 3 | -1.6760249 | -1.3410914 |
|
| G1 to S phase transition 1 | -1.3995273 | -1.0519781 |
|
| glutathione S-transferase alpha 4 | -1.1619577 | -1.0276983 |
|
| hairy and enhancer of split 4 (Drosophila) | -1.1826415 | -2.0193136 |
|
| high mobility group box 1 | -1.002748 | -1.2596858 |
|
| high mobility group box 3 | -1.2634602 | -1.1885982 |
|
| heat shock 70kDa protein 4 | -1.5835454 | -1.2644181 |
|
| interferon, gamma-inducible protein 30 | -1.5613956 | -1.5471194 |
|
| interferon-related developmental regulator 2 | -1.1622665 | -1.0979714 |
|
| junctophilin 1 | -1.1266716 | -1.6309524 |
|
| nuclear receptor-binding protein 2-like /// nuclear receptor binding protein 2 | -1.5101182 | -1.0871661 |
|
| mitochondrial poly(A) polymerase | -2.2048273 | -1.046771 |
|
| neuralized homolog 1B (Drosophila) | -1.2790649 | -1.0592682 |
|
| nuclear factor I/A | -1.2247176 | -1.1426408 |
|
| poly (ADP-ribose) polymerase 1 | -1.6084354 | -1.0683279 |
|
| phosphorylase kinase, alpha 1 (muscle) | -1.4648097 | -1.3255553 |
|
| plexin A1 | -1.1962962 | -1.3295693 |
|
| polyribonucleotide nucleotidyltransferase 1 | -1.3692455 | -1.0695791 |
|
| polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) | -1.0398519 | -1.1780653 |
|
| retinoblastoma binding protein 4 | -1.0829744 | -1.1924767 |
|
| tubulin, beta class I | -1.1920624 | -1.0390439 |
Table shows a section of commonly deregulated genes under microgravity in both cell lines as revealed by microarray analysis. The complete list of genes is provided in S5 Table.
Fig 4Effect of microgravity on gene expression levels in DLD-1 and MOLT-4 cell cultures; Validation of microarray analysis by real time PCR and western blotting.
A Log fold change of CCNB1, ROMO1 and HES1 deregulation in MOLT-4 cells under microgravity as observed by microarray analysis validated by real time PCR B Log fold change of CDK2, HEY1 and STAT3 deregulation in DLD-1 cells under microgravity as observed by microarray analysis validated by real time PCR C Log fold change of commonly up and downregulated genes CCNE1, TFRC (CD71) and CD44 as observed by microarray analysis validated by real time PCR forCCNE1 and TFRC (CD71).
Fig 5Dysregulation of stem cell marker CD44 and tumor suppressor microRNA under microgravity.
A Validation of microarray data for CD44 by Western blotting for CD44 protein and beta-actin in static and Microgravity (μG) cultures of DLD1 and MOLT-4 and Densitometric analysis of western blots. B MIR22HG expression under microgravity; Overexpressed MIR22HG, host gene of miR-22 microRNA in DLD-1 cells under microgravity, MOLT-4 cells show no differential expression; Levels of dysregulation of direct targets of miR-22 microRNA CDK6, CCNA2, SP1 and CDKN1A in microarray data; RT-PCR validation of microRNA miR-22 levels and target genes in DLD-1 shows over expressed microRNA miR-22 in DLD-1 cells under microgravity confirming upregulation in microarray data. No significant dysregulation of direct targets CDKN1A (similar to expression levels in microarray data) and CCND1A C GO analysis (by DAVID) of microarray data to depict other dysregulated microRNA host genes in DLD-1 and MOLT-4 cells under microgravity.
Fig 6Analysis of microarray data using Gene Functional Classification and Functional Annotation; Dysregulation of genes involved in the Notch signaling system and microRNA processing and regulation.
A Regulation of transcription B RNA mediated gene silencing (PTGS) C Notch signaling pathway D Dysregulated microRNA processors and regulators.
Fig 7Functional annotation of microarray data using DAVID.
A Functional annotation of upregulated and downregulated genes of DLD-1 cells under microgravity B Functional annotation of upregulated and downregulated genes of MOLT-4 cells under microgravity.